Literature DB >> 9774339

Pathogenic poxviruses reveal viral strategies to exploit the ErbB signaling network.

E Tzahar1, J D Moyer, H Waterman, E G Barbacci, J Bao, G Levkowitz, M Shelly, S Strano, R Pinkas-Kramarski, J H Pierce, G C Andrews, Y Yarden.   

Abstract

Virulence of poxviruses, the causative agents of smallpox, depends on virus-encoded growth factors related to the mammalian epidermal growth factor (EGF). Here we report that the growth factors of Shope fibroma virus, Myxoma virus and vaccinia virus (SFGF, MGF and VGF) display unique patterns of specificity to ErbB receptor tyrosine kinases; whereas SFGF is a broad-specificity ligand, VGF binds primarily to ErbB-1 homodimers, and the exclusive receptor for MGF is a heterodimer comprised of ErbB-2 and ErbB-3. In spite of 10- to 1000-fold lower binding affinity to their respective receptors, the viral ligands are mitogenically equivalent or even more potent than their mammalian counterparts. This remarkable enhancement of cell growth is due to attenuation of receptor degradation and ubiquitination, which leads to sustained signal transduction. Our results imply that signal potentiation and precise targeting to specific receptor combinations contribute to cell transformation at sites of poxvirus infection, and they underscore the importance of the often ignored low-affinity ligand-receptor interactions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9774339      PMCID: PMC1170922          DOI: 10.1093/emboj/17.20.5948

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  69 in total

Review 1.  Neuregulins and their receptors: a versatile signaling module in organogenesis and oncogenesis.

Authors:  S Burden; Y Yarden
Journal:  Neuron       Date:  1997-06       Impact factor: 17.173

Review 2.  Vulval development in Caenorhabditis elegans.

Authors:  K Kornfeld
Journal:  Trends Genet       Date:  1997-02       Impact factor: 11.639

3.  Detection of ERK activation by a novel monoclonal antibody.

Authors:  Y Yung; Y Dolginov; Z Yao; H Rubinfeld; D Michael; T Hanoch; E Roubini; Z Lando; D Zharhary; R Seger
Journal:  FEBS Lett       Date:  1997-05-26       Impact factor: 4.124

4.  The cellular response to neuregulins is governed by complex interactions of the erbB receptor family.

Authors:  D J Riese; T M van Raaij; G D Plowman; G C Andrews; D F Stern
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

Review 5.  Epidermal growth factor-related peptides and their receptors in human malignancies.

Authors:  D S Salomon; R Brandt; F Ciardiello; N Normanno
Journal:  Crit Rev Oncol Hematol       Date:  1995-07       Impact factor: 6.312

6.  The relationship between human epidermal growth-like factor receptor expression and cellular transformation in NIH3T3 cells.

Authors:  B D Cohen; P A Kiener; J M Green; L Foy; H P Fell; K Zhang
Journal:  J Biol Chem       Date:  1996-11-29       Impact factor: 5.157

7.  Control of EGF receptor signaling by clathrin-mediated endocytosis.

Authors:  A V Vieira; C Lamaze; S L Schmid
Journal:  Science       Date:  1996-12-20       Impact factor: 47.728

8.  HER4 receptor activation and phosphorylation of Shc proteins by recombinant heregulin-Fc fusion proteins.

Authors:  J M Culouscou; G W Carlton; A Aruffo
Journal:  J Biol Chem       Date:  1995-05-26       Impact factor: 5.157

9.  ErbB-3 mediates differential mitogenic effects of NDF/heregulin isoforms on mouse keratinocytes.

Authors:  M Marikovsky; S Lavi; R Pinkas-Kramarski; D Karunagaran; N Liu; D Wen; Y Yarden
Journal:  Oncogene       Date:  1995-04-06       Impact factor: 9.867

10.  Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas.

Authors:  M Alimandi; A Romano; M C Curia; R Muraro; P Fedi; S A Aaronson; P P Di Fiore; M H Kraus
Journal:  Oncogene       Date:  1995-05-04       Impact factor: 9.867

View more
  40 in total

1.  The C-terminus of the kinase-defective neuregulin receptor ErbB-3 confers mitogenic superiority and dictates endocytic routing.

Authors:  H Waterman; I Alroy; S Strano; R Seger; Y Yarden
Journal:  EMBO J       Date:  1999-06-15       Impact factor: 11.598

2.  Poxvirus-induced immunostimulating effects on porcine leukocytes.

Authors:  V Fachinger; T Schlapp; W Strube; N Schmeer; A Saalmüller
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

Review 3.  The ErbB signaling network: receptor heterodimerization in development and cancer.

Authors:  M A Olayioye; R M Neve; H A Lane; N E Hynes
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

4.  The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors.

Authors:  L N Klapper; S Glathe; N Vaisman; N E Hynes; G C Andrews; M Sela; Y Yarden
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

5.  The vaccinia virus-stimulated mitogen-activated protein kinase (MAPK) pathway is required for virus multiplication.

Authors:  Anderson A Andrade; Patrícia N G Silva; Anna C T C Pereira; Lirlândia P De Sousa; Paulo C P Ferreira; Ricardo T Gazzinelli; Erna G Kroon; Catherine Ropert; Cláudio A Bonjardim
Journal:  Biochem J       Date:  2004-07-15       Impact factor: 3.857

6.  Antiviral chemotherapy facilitates control of poxvirus infections through inhibition of cellular signal transduction.

Authors:  Hailin Yang; Sung-Kwon Kim; Mikyung Kim; Pedro A Reche; Tiara J Morehead; Inger K Damon; Raymond M Welsh; Ellis L Reinherz
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

7.  The cytomegalovirus UL146 gene product vCXCL1 targets both CXCR1 and CXCR2 as an agonist.

Authors:  Hans R Lüttichau
Journal:  J Biol Chem       Date:  2009-12-31       Impact factor: 5.157

8.  An antibody to amphiregulin, an abundant growth factor in patients' fluids, inhibits ovarian tumors.

Authors:  S Carvalho; M Lindzen; M Lauriola; N Shirazi; S Sinha; A Abdul-Hai; K Levanon; J Korach; I Barshack; Y Cohen; A Onn; G Mills; Y Yarden
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

Review 9.  Endocytosis and cancer.

Authors:  Ira Mellman; Yosef Yarden
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-12-01       Impact factor: 10.005

10.  Lister strain of vaccinia virus armed with endostatin-angiostatin fusion gene as a novel therapeutic agent for human pancreatic cancer.

Authors:  J R Tysome; A Briat; G Alusi; F Cao; D Gao; J Yu; P Wang; S Yang; Z Dong; S Wang; L Deng; J Francis; T Timiryasova; I Fodor; N R Lemoine; Y Wang
Journal:  Gene Ther       Date:  2009-07-09       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.